The Paradigm Shift in Advanced Skincare: From Bioactive Ingredients to Bio-mimetic Delivery Systems

Posted on by

Strategic Analysis of Nano-Encapsulated Retinaldehyde (NanoActive®RAL) as a High-Performance Alternative to Energy-Based Devices

1. The Evolution of Efficacy: Transitioning to “Clinical-Grade” Topical Solutions

The global skincare market is undergoing a fundamental shift from “Ingredient-Focused” (focusing on raw percentages) to “Science-Driven” (focusing on targeted delivery and bioavailability). A significant catalyst for this shift, particularly in the Asian and European markets, has been the 2024 regulatory tightening of home-use radiofrequency (RF) devices.As these devices are reclassified as medical instruments, a massive market gap has emerged for “RF-like” topical solutions capable of delivering measurable collagen-stimulating and skin-tightening results.

In this landscape,PuriPharm’s NanoActive® Retinal (RAL)delivery system has emerged as a premier commercial entry point. By leveraging pharmaceutical-grade nano-liposomes, PuriPharm addresses the historical “Triple Challenge” of Retinaldehyde: extreme instability, poor penetration, and high irritation potential.

2. Biochemical Logic: Why Retinaldehyde Outperforms Retinol

Vitamin A derivatives (retinoids) remain the gold standard in dermatology for stimulating the extracellular matrix (ECM). Their efficacy is determined by their proximity to Retinoic Acid in the metabolic pathway .

The “11x Efficiency” Factor

Traditional Retinol requires a two-step enzymatic oxidation to become active. In contrast, Retinaldehyde (RAL) is only one step away from Retinoic Acid. Scientific studies indicate that Retinaldehyde is approximately 11 times more efficientin bio-conversion than Retinol . This allows for significantly faster results in collagen synthesis, texture refinement, and wrinkle reduction even at lower concentrations .

3. NanoActive® Delivery System: Pharmaceutical-Grade Innovation

PuriPharm utilizes its proprietary Nano-Delivery System (NDS) to stabilize the “wild” nature of Retinaldehyde.

Ultra-Small Liposomal Architecture (<30nm)

NanoActive® RAL features a particle size precisely engineered to beunder 30nm (typically 20-30nm).This ultra-small scale, combined with a biomimetic phospholipid bilayer, provides two critical advantages:

1.Deep Dermal Penetration: The liposomal structure mimics skin cell membranes, allowing the active to bypass the stratum corneum and reach the deeper dermis more effectively than traditional emulsions.

2.“De-noising” Sustained Release: By encapsulating the RAL, the system provides a controlled release of the active. This “de-noising” process ensures a steady supply of energy to the skin while minimizing the common “Retinoid reaction” (redness, peeling, and stinging), making it suitable for sensitive skin types .

4. Clinical Evidence: Quantifiable Collagen Remodeling

The efficacy of PuriPharm’s NanoActive® RAL is substantiated by rigorous clinical testing. A 4-week independent human efficacy study conducted byIntertek (30 subjects, age 35-55) demonstrated the following results:

Instrument-Based Results (PRIMOS Analysis)

●Forehead Wrinkles: Count reduced by27.67%, total area reduced by11.98%.

●Crow’s Feet: Count reduced by31.05%, total area reduced by12.45%.

●Brightening (L Value)*: Significant increase in skin luminosity and ITA value, confirming a secondary whitening effect.

Subjective Satisfaction

●96.7% overall product satisfaction.

●93.3% of subjects reported visible improvements in skin firmness and elasticity.

●90.0% satisfaction regarding the reduction of fine lines under the eyes.

5. Innovation Highlight: NanoActive RETINAMIDE

For brands seeking “Day-to-Night” anti-aging solutions, PuriPharm has developed NanoActive RETINAMIDE, a stable amide derivative of retinoic acid conjugated with Polyethylene Glycol (PEG).

●Amide Bond Stability: Unlike HPR (Hydroxypinacolone Retinoate), RETINAMIDE is highly stable and does not hydrolyze into prohibited retinoic acid during shelf life.

●Daytime Capability: Due to its enhanced photo-stability and hydrophilic nature, it can be used during the day (when paired with SPF) to provide 24-hour collagen remodeling.

●Post-Procedure Recovery: It is exceptionally gentle, making it ideal for skin barrier repair and collagen maintenance following professional treatments like laser or microneedling.

6. The “Triple Threat” Synergy Strategy

PuriPharm’s NDS platform offers Universal Nano-Compatibility, allowing formulators to combine multiple nano-actives without risking physical instability or greasy textures.5A recommended high-performance matrix includes:

●NanoActive® RAL: Stimulates gene expression for collagen I and III synthesis.

●NanoActive® Silybin: A potent phyto-retinol that promotes regeneration while down-regulating pro-inflammatory cytokines to mitigate irritation .

●NanoActive® Hexylresorcinol: Reinforces the dermal support structure while inhibiting melanin for a unified, firm complexion.

7. Global Regulatory Compliance: EU 2024/996 Positioning

The latest EU Regulation 2024/996 restricts Retinol Equivalents (RE) to 0.3% for leave-on face products. This regulation heavily favors high-efficiency molecules like Retinaldehyde.

●Efficiency over Concentration: Because Retinaldehyde is 11x more active than Retinol, a 0.3% RAL concentration delivered via NanoActive® technology can provide anti-aging results comparable to unregulated 1.0%+ Retinol products from the past .

●Compliance Support: PuriPharm provides full in-vitro and clinical data to support “Anti-Wrinkle” and “Firming” claims under strict international labeling requirements.

Conclusion

The surge in demand for nano-encapsulated Retinaldehyde reflects a broader market return to technical excellence. PuriPharm’s NanoActive® delivery system does more than stabilize a volatile molecule; it simulates the biological effects of RF technology through a non-invasive, high-precision delivery platform. With its 31.05% reduction in wrinkle countand11x metabolic efficiency, NanoActive® RAL is not just a raw material—it is the strategic cornerstone for the next generation of “Clinic-at-Home” skincare.

Works cited

1.家用美容仪- MCR嘉世咨询, accessed April 3, 2026,

2.Retinal vs Retinol | Stabilization, Encapsulation & Claim Limits – Grand Ingredients, accessed April 3, 2026,

3.Platform Technology – PuriPharm, accessed April 3, 2026,

4.Anti acne oil control – PuriPharm, accessed April 3, 2026,

5.上海市化妆品行业广告宣传合规指引-广告监督管理, accessed April 3, 2026,

6.玻色因纳米视黄醛精华人体功效测试报告.pdf

7.NanoActive RETINAMIDE – PuriPharm, accessed April 3, 2026,

8.Bio-nest Biochemical Technology – Covalo, accessed April 3, 2026,

9.化妆品广告宣传合规指南-专业文章, accessed April 3, 2026,

Product Data Sheet: NanoActive Retinol

Posted on by

Manufacturer：PuriPharm Co., Ltd.

Product Name：NanoActive Retinol

Product Category：Stable, Water-soluble, High-absorption Vitamin A

1. Product Description

NanoActive Retinol is a novel preparation developed using a proprietary nano-delivery system. With a particle size ranging between 20-30 nm, this system effectively stabilizes Retinol within nano-carriers. This technology ensures deep skin penetration for maximum efficacy, controlled release, and significantly reduced irritation compared to conventional retinoic acid.

2. Product Identification (INCI)

  • RETINOL (CAS #: 116-31-4)
  • PHOSPHOLIPIDS (CAS #: 123465-35-0)
  • CAPRYLIC/CAPRIC TRIGLYCERIDE (CAS #: 65381-09-1)
  • GLYCERIN (CAS #: 56-81-5)
  • WATER (CAS #: 7732-18-5)

3. Key Benefits & Efficacy

  • Anti-Aging & Anti-Wrinkle: Stimulates collagen and elastin production; increases epidermal thickness and elasticity.
  • Skin Renewal: Enhances cell turnover rate for smoother skin texture.
  • Brightening: Inhibits tyrosinase expression and melanin synthesis to reduce pigmentation and even skin tone.
  • Acne Care: Regulates sebum production and targets acne-causing bacteria (e.g., P. acnes).
  • High Stability & Safety: Significantly improves Retinol stability and minimizes the irritation typically associated with Vitamin A derivatives.
  • Enhanced Bioavailability: Nano-encapsulation ensures high absorption and effective penetration into skin layers.

4. Technical Specifications

4.1. Physical & Chemical Properties

4.2. Chemical Indexes

4.3. Microbiological Indexes

5. Application & Formulation Guidelines

  • Recommended Usage: 0.1% – 1.0%
  • Optimum pH Range: 4.5 – 8.0
  • Application Method: Add to the formula during the final stage of production.
  • Formulation Tips: * Primarily used in night care products.
  • For daytime products, photoprotective agents must be added.
  • Opaque packaging is highly recommended to protect the active ingredient.

6. Storage & Handling

  • Preservatives & Antioxidants: Free from added preservatives and antioxidants.
  • Storage Conditions: Store in original, unopened containers between and . Protect from direct sunlight and moisture.
  • Shelf Life: 12 months from the date of manufacture under recommended conditions.
  • Packaging: Standard plastic containers.

PuriPharm Co., Ltd.Address: 7th Floor, 6E Building, No. 1366 Hongfeng Road, Huzhou, Zhejiang, ChinaTel: 0572-2745768 | Email: service@puripharm.com

PuriActives® 7-DHC

Posted on by

Vitamin D3 Precursor for Skin Resilience & Renewal

INNOVATION IN SKIN SCIENCE

PURIPHARM BRAND ARCHITECTURE

7-DHC: THE RESILIENCE ANCHOR

ADDRESSING MODERN SKIN STRESS

BEYOND BASIC MOISTURE

MARKET DEMAND FOR RESILIENCE

WHAT IS 7-DEHYDROCHOLESTEROL?

PURIACTIVES® 7-DHC BENEFITS

THE BIOLOGICAL PATHWAY

CELLULAR STRESS RESILIENCE

POST-SUN COMFORT

BIOLOGICAL BALANCE & RENEWAL

SUBSTANTIATION SUMMARY

HSP MRNA UPREGULATION

PILOT STUDY RESULTS

CLAIM DIRECTION GUIDE

TECHNICAL GUIDANCE

PRODUCT CONCEPT PROTOTYPES

COMPLIANCE & SAFETY

THE MARKETING EDGE

NanoActive® 7-DHC THE SKIN-NATIVE PROVITAMIN D PLATFORM

Posted on by
Executive Overview
Science-Backed Innovation
PuriPharmis a leading specialist in the design and manufacture of high-functional cosmetic active ingredients and advanced delivery platforms.
Our mission is to empower global B2B customers with biologically meaningful solutions that translate complex cellular science into commercially successful skincare products.
PuriPharmBrand Framework
Why 7-DHC Matters
Endogenous Relevance
7-dehydrocholesterol (7-DHC) is a skin-native precursor produced naturally in the human epidermis.
As a key intermediate in the cholesterol biosynthetic pathway, it represents a truebiomimeticapproach to skin health, aligning with the skin’s inherent chemistry.
 
The Provitamin D Pathway
Homeostatic Skin Support
Translating Science to Beauty
The Delivery Advantage
The 7-DHC Innovation Platform
Beyond Traditional Actives
NanoActive® 7-DHC represents more than an ingredient—it is abiological platformfor brands seeking the next frontier in skin resilience.
By mimicking endogenous pathways, it offers a “Biology-First” marketing angle that resonates with sophisticated, research-driven consumers.
Mechanism of Action
Evidence Hierarchy
Polished Claim Map
Formulation Guidelines
Concept Applications
Target Consumer Needs
 
The Differentiation Edge
Commercial Strategic Value
Key Takeaways
 

Retinal (Retinaldehyde) Market Outlook & Strategic Analysis Report

Posted on by
You need to add a widget, row, or prebuilt layout before you’ll see anything here. 🙂

I. Background:

The “EU Vitamin A Restriction” Shaking the Industry

The formal implementation of Regulation (EU) 2024/996 marks a pivotal regulatory turning point for Vitamin A derivatives in the skincare industry.

1. Key Regulatory Highlights

  • Concentration Thresholds: From November 1, 2025, new face and leave-on products must not exceed 0.3% Retinol Equivalent (RE); body lotions are limited to 0.05% RE.
  • Grace Period: Non-compliant products already on the market must be withdrawn by May 1, 2027.
  • Mandatory Labeling: Products must include a warning: “Contains Vitamin A. Consider your daily intake before use.”

2. Industry Ripple Effects

This regulation forces a paradigm shift from “High Concentration” to “High Efficiency.” Retinal (Retinaldehyde), the direct precursor to Retinoic Acid, has emerged as the premier alternative to Retinol, offering superior performance within the new legal limits.

II. Core Value:

Why Retinal is the “Optimal Solution”

Under the 0.3% concentration cap, Retinal provides a much higher “performance ceiling” compared to Retinol.

  • Conversion Efficiency: Retinal requires only one conversion step to become Retinoic Acid (the active form), whereas Retinol requires two. Research indicates Retinal’s bio-activity is approximately 10-11 times more efficient than Retinol.
  • Compliance Advantage: At the 0.3% EU limit, Retinal can deliver anti-aging results comparable to unregulated high-concentration Retinol (1.0%+) products of the past.
  • Antibacterial Benefits: Unlike Retinol, Retinal possesses natural antimicrobial activity, making it a unique solution for the “adult acne & anti-aging” dual-segment.

III. Technical Strategy:

Advanced Delivery & Synergistic Formulas

To overcome Retinal’s inherent instability, the following next-generation combinations are recommended:

1. Retinal + Silybin (Phyto-Retinol Strategy):

  • Silybin is highlighted as the premier plant-based Retinol alternative. It promotes collagen regeneration via “Retinoid-like” pathways without the irritation.
  • Its potent anti-inflammatory properties significantly down-regulate pro-inflammatory cytokines, mitigating the potential irritation often associated with Retinal.

2. Retinal + Hexylresorcinol (Multi-Target Aging):

  • Hexylresorcinol inhibits melanin synthesis while reinforcing the dermal support structure.
  • This synergy achieves a “1+1>2” effect for intensive wrinkle reduction and skin tone brightening.

IV. Core Competitive Advantages of PuriPharm

As a leader in Nano-Delivery Systems (NDS), PuriPharm is uniquely positioned to solve the stability and penetration challenges of Retinal:

1. Pharmaceutical-Grade Nano-Encapsulation (NanoActive®)

  • Solving Stability Issues: Retinal is extremely sensitive to light and oxygen. PuriPharm’s Nano-Liposome technology isolates the active from environmental factors, ensuring long-term potency.
  • Enhanced Skin Penetration: With particle sizes typically below 30nm, NanoActive® RAL (Retinal) penetrates the skin barrier more effectively than traditional formulations, reaching the deeper dermis.
  • Reduced Irritation (De-noising): Controlled release technology ensures a steady delivery of actives, minimizing the “Retinoid reaction” (redness and peeling).

2. Comprehensive Synergistic Ingredient Portfolio

  • PuriPharm provides a complete suite of nano-encapsulated actives, including NanoActive® RAL, NanoActive® Silybin, and NanoActive® Hexylresorcinol.
  • Universal Nano-Compatibility allows formulators to combine these “Triple Threat” ingredients seamlessly, ensuring physical stability and a premium, non-greasy skin feel.

3. Professional R&D & Data Support

● Backed by a founding team with deep pharmaceutical backgrounds, PuriPharm provides robust in-vitro and clinical efficacy data. This assists global brands in justifying their claims and navigating strict EU labeling requirements.

V. Strategic Opportunities for the International Market

  1. “Concentration-to-Efficiency” Rebranding: Help brands leverage 0.3% Retinal Nano-products to outperform 1.0% Retinol competitors in efficacy.
  2. Global Compliance Transition: Provide ready-to-use, EU-compliant ingredient solutions and stability dossiers for brands looking to enter or stay in the European market.
  3. Custom NDS Development: Utilize the NDS platform to create exclusive “Retinal + X” nano-complexes, building a proprietary technical moat for the brand.

VI. Conclusion

The EU Vitamin A restriction is not an end, but the beginning of the “Era of Scientific Anti-Aging.” By utilizing PuriPharm’s Nano-Delivery Systems to master the stability and delivery of Retinal, brands can achieve market dominance in the post-retinol landscape.

Retinal (Retinaldehyde) Market Outlook & Strategic Analysis Report

Posted on by

I. Background:

The “EU Vitamin A Restriction” Shaking the Industry

The formal implementation of Regulation (EU) 2024/996 marks a pivotal regulatory turning point for Vitamin A derivatives in the skincare industry.

1. Key Regulatory Highlights

  • Concentration Thresholds: From November 1, 2025, new face and leave-on products must not exceed 0.3% Retinol Equivalent (RE); body lotions are limited to 0.05% RE.
  • Grace Period: Non-compliant products already on the market must be withdrawn by May 1, 2027.
  • Mandatory Labeling: Products must include a warning: “Contains Vitamin A. Consider your daily intake before use.”

2. Industry Ripple Effects

This regulation forces a paradigm shift from “High Concentration” to “High Efficiency.” Retinal (Retinaldehyde), the direct precursor to Retinoic Acid, has emerged as the premier alternative to Retinol, offering superior performance within the new legal limits.

II. Core Value:

Why Retinal is the “Optimal Solution”

Under the 0.3% concentration cap, Retinal provides a much higher “performance ceiling” compared to Retinol.

  • Conversion Efficiency: Retinal requires only one conversion step to become Retinoic Acid (the active form), whereas Retinol requires two. Research indicates Retinal’s bio-activity is approximately 10-11 times more efficient than Retinol.
  • Compliance Advantage: At the 0.3% EU limit, Retinal can deliver anti-aging results comparable to unregulated high-concentration Retinol (1.0%+) products of the past.
  • Antibacterial Benefits: Unlike Retinol, Retinal possesses natural antimicrobial activity, making it a unique solution for the “adult acne & anti-aging” dual-segment.

III. Technical Strategy:

Advanced Delivery & Synergistic Formulas

To overcome Retinal’s inherent instability, the following next-generation combinations are recommended:

1. Retinal + Silybin (Phyto-Retinol Strategy):

  • Silybin is highlighted as the premier plant-based Retinol alternative. It promotes collagen regeneration via “Retinoid-like” pathways without the irritation.
  • Its potent anti-inflammatory properties significantly down-regulate pro-inflammatory cytokines, mitigating the potential irritation often associated with Retinal.

2. Retinal + Hexylresorcinol (Multi-Target Aging):

  • Hexylresorcinol inhibits melanin synthesis while reinforcing the dermal support structure.
  • This synergy achieves a “1+1>2” effect for intensive wrinkle reduction and skin tone brightening.

IV. Core Competitive Advantages of PuriPharm

As a leader in Nano-Delivery Systems (NDS), PuriPharm is uniquely positioned to solve the stability and penetration challenges of Retinal:

1. Pharmaceutical-Grade Nano-Encapsulation (NanoActive®)

  • Solving Stability Issues: Retinal is extremely sensitive to light and oxygen. PuriPharm’s Nano-Liposome technology isolates the active from environmental factors, ensuring long-term potency.
  • Enhanced Skin Penetration: With particle sizes typically below 30nm, NanoActive® RAL (Retinal) penetrates the skin barrier more effectively than traditional formulations, reaching the deeper dermis.
  • Reduced Irritation (De-noising): Controlled release technology ensures a steady delivery of actives, minimizing the “Retinoid reaction” (redness and peeling).

2. Comprehensive Synergistic Ingredient Portfolio

PuriPharm provides a complete suite of nano-encapsulated actives, including NanoActive® RAL, NanoActive® Silybin, and NanoActive® Hexylresorcinol.

Universal Nano-Compatibility allows formulators to combine these “Triple Threat” ingredients seamlessly, ensuring physical stability and a premium, non-greasy skin feel.

3. Professional R&D & Data Support

  • Backed by a founding team with deep pharmaceutical backgrounds, PuriPharm provides robust in-vitro and clinical efficacy data. This assists global brands in justifying their claims and navigating strict EU labeling requirements.

V. Strategic Opportunities for the International Market

  1. Concentration-to-Efficiency Rebranding: Help brands leverage 0.3% Retinal Nano-products to outperform 1.0% Retinol competitors in efficacy.
  2. Global Compliance Transition: Provide ready-to-use, EU-compliant ingredient solutions and stability dossiers for brands looking to enter or stay in the European market.
  3. Custom NDS Development: Utilize the NDS platform to create exclusive “Retinal + X” nano-complexes, building a proprietary technical moat for the brand.

VI. Conclusion

The EU Vitamin A restriction is not an end, but the beginning of the “Era of Scientific Anti-Aging.” By utilizing PuriPharm’s Nano-Delivery Systems to master the stability and delivery of Retinal, brands can achieve market dominance in the post-retinol landscape.

NanoActive Oridonin(Liposomal Oridonin)

Posted on by

Stable Water-Soluble Oridonin

Product Overview

NanoActive Oridonin represents a groundbreaking advancement in cosmetic active ingredients, combining the potent bioactive properties of oridonin with state-of-the-art liposomal delivery technology. As part of PuriPharm’s prestigious NanoActive® series, this innovative ingredient addresses multiple signs of skin aging through a sophisticated multi-target approach, making it an exceptional choice for premium skincare formulations targeting skin tone improvement and overall skin revitalization.

Oridonin, a bioactive diterpenoid compound naturally occurring in Rabdosia rubescens, has been extensively studied for its remarkable biological activities. However, its practical application in cosmetic formulations has been historically limited due to poor water solubility and stability challenges. PuriPharm has successfully overcome these obstacles through advanced liposomal encapsulation technology, creating a stable, water-soluble form that maintains full bioactivity while ensuring optimal skin penetration and sustained release.

Product Identification

Key Benefits

NanoActive Oridonin delivers comprehensive skin tone enhancement through its unique ability to address three fundamental visible skin pigments that serve as true markers of skin aging. This triple-action mechanism sets it apart from conventional brightening ingredients that typically target only melanin production.

Melanin Reduction

NanoActive Oridonin effectively inhibits melanogenesis through multiple pathways, reducing the appearance of hyperpigmentation, age spots, and uneven skin tone. The liposomal delivery system ensures that the active compound reaches melanocytes in the basal layer of the epidermis, where it modulates tyrosinase activity and interrupts the melanin synthesis cascade. Clinical observations have demonstrated significant improvements in skin luminosity and reduction in pigmented lesions with consistent application.

Hemoglobin Modulation

Unlike most brightening agents, NanoActive Oridonin also addresses vascular-related skin discoloration by modulating hemoglobin visibility. This is particularly beneficial for reducing the appearance of facial redness, telangiectasia, and post-inflammatory erythema. The compound’s anti-inflammatory properties help calm irritated skin while strengthening capillary walls, resulting in a more uniform and balanced complexion. This dual-action approach to both melanin and hemoglobin makes it exceptionally effective for individuals with complex skin tone concerns.

Collagen Synthesis Enhancement

Beyond pigment correction, NanoActive Oridonin actively promotes collagen synthesis in dermal fibroblasts. This pro-collagen activity helps restore skin firmness and elasticity while reducing the appearance of fine lines and wrinkles. The compound stimulates fibroblast proliferation and upregulates type I collagen production, contributing to overall skin rejuvenation. This comprehensive approach ensures that skin not only appears more even-toned but also demonstrates improved texture and youthful resilience.

Mechanism of Action

The efficacy of NanoActive Oridonin stems from its sophisticated multi-target mechanism that addresses skin aging at the cellular level. Understanding these mechanisms is essential for formulators seeking to maximize the ingredient’s potential in their product development.

Upon application, the liposomal carriers penetrate the stratum corneum through intercellular lipid pathways, delivering the encapsulated oridonin to targeted skin layers. The phospholipid bilayer structure of the liposomes mimics natural cell membranes, facilitating fusion with keratinocyte membranes and enabling efficient intracellular delivery. This targeted delivery system significantly enhances bioavailability compared to conventional formulations, ensuring that a higher percentage of the active compound reaches its intended site of action.

Once released, oridonin interacts with multiple cellular signaling pathways. It modulates the expression of melanogenesis-related enzymes, including tyrosinase, TRP-1, and TRP-2, through downregulation of MITF (microphthalmia-associated transcription factor). Simultaneously, it activates TGF-beta signaling pathways that promote collagen synthesis while inhibiting MMP enzymes responsible for collagen degradation. This coordinated action results in visible improvements in skin tone, texture, and overall appearance.

Technical Advantages

The liposomal encapsulation technology employed in NanoActive Oridonin represents a significant advancement in cosmetic ingredient delivery systems. This sophisticated approach addresses the inherent challenges associated with oridonin while unlocking its full therapeutic potential for skincare applications.

  • Enhanced Stability: The liposomal encapsulation protects oridonin from oxidation, photodegradation, and chemical degradation, ensuring consistent potency throughout the product shelf life. This stability enhancement allows formulators to create products with extended shelf stability without compromising efficacy.
  • Superior Water Solubility: The transformation from a poorly water-soluble compound to a readily dispersible liposomal suspension enables seamless integration into aqueous formulations, expanding formulation possibilities for serums, essences, and lightweight moisturizers.
  • Optimized Skin Penetration: Liposomal carriers enhance transdermal delivery by facilitating passage through the stratum corneum and promoting accumulation in the epidermis and upper dermis, where the active compound can exert its beneficial effects on melanocytes and fibroblasts.
  • Sustained Release Profile: The controlled release mechanism ensures prolonged activity at the target site, reducing the frequency of application needed to achieve optimal results while minimizing potential irritation from concentrated exposure.
  • Biocompatible Delivery System: The phospholipid-based liposomes are biocompatible and well-tolerated by all skin types, including sensitive and compromised skin barriers, making NanoActive Oridonin suitable for a wide range of cosmetic applications.

Recommended Applications

NanoActive Oridonin’s versatile profile makes it an ideal active ingredient for various premium skincare formulations. Its water-soluble nature and excellent stability allow for flexible incorporation into diverse product formats, enabling formulators to create innovative solutions for comprehensive skin tone correction and anti-aging benefits.

  • Brightening and whitening serums targeting hyperpigmentation and age spots
  • Anti-aging creams and lotions with comprehensive rejuvenation benefits
  • Skin tone evening treatments for redness-prone and uneven complexions
  • Post-procedure recovery formulations designed to calm and restore skin
  • Premium facial essences and treatment concentrates for intensive care
  • Multi-functional day and night creams with tone-correcting properties

About PuriPharm Co. Ltd.

PuriPharm Co. Ltd. is a leading innovator in the development and manufacturing of high-performance cosmetic active ingredients. With a strong commitment to scientific research and technological advancement, PuriPharm has established itself as a trusted partner for cosmetic formulators worldwide, delivering cutting-edge solutions that meet the evolving demands of the global beauty industry.

The company’s two flagship brand series, PuriActives® and NanoActive®, represent the pinnacle of cosmetic ingredient innovation. The PuriActives® series focuses on purified, high-potency active compounds derived from natural sources, while the NanoActive® series showcases PuriPharm’s expertise in advanced delivery systems, including liposomal, nanoemulsion, and encapsulation technologies. Together, these product lines offer formulators a comprehensive portfolio of solutions for creating next-generation skincare products.

PuriPharm maintains rigorous quality standards throughout its manufacturing processes, with state-of-the-art facilities equipped for advanced extraction, purification, and nano-formulation technologies. The company’s dedicated research and development team continuously explores new frontiers in cosmetic science, ensuring that PuriPharm remains at the forefront of ingredient innovation. By combining traditional botanical wisdom with modern scientific methodologies, PuriPharm creates ingredients that deliver measurable results while meeting the highest standards of safety and efficacy.

Contact Information

For product inquiries, technical support, or partnership opportunities:

PuriPharm Co. Ltd.

Website: www.puripharm.com

Product Series: PuriActives® | NanoActive®

NanoActive® RAL (Liposomal Retinal) Advanced Vitamin A Technology for High-Performance Skin Care

Posted on by

Company & Brand Background

PuriPharm Co. Ltd. is a science-driven company specializing in the research, development, and commercialization of high-performance functional bioactive ingredients. With a strong foundation in pharmaceutical science, biotechnology, and advanced formulation technologies, PuriPharm is dedicated to delivering safe, effective, and innovative active ingredient solutions for the global cosmetics, personal care, and biomedical industries.

PuriPharm operates two core product platforms:

• PuriActives® – a portfolio of high-quality functional bioactives derived from natural, bio-based, and scientifically validated sources.

• NanoActive® – an advanced nano-delivery ingredient platform designed to enhance the stability, bioavailability, and efficacy of sensitive active compounds through cutting-edge encapsulation technologies.

NanoActive® RAL (Liposomal Retinal) is a flagship product of the NanoActive® series, representing PuriPharm’s expertise in vitamin A chemistry, lipid delivery systems, and skin bioavailability optimization.

Retinal, also known as retinaldehyde (RAL), is a highly active form of vitamin A and a direct biochemical precursor of retinoic acid, the biologically active molecule responsible for many of vitamin A’s well-known skin benefits.

Unlike retinol, which requires a two-step enzymatic conversion process in the skin, retinal converts to retinoic acid in only one step. As a result, retinal delivers faster and more efficient biological activity at significantly lower concentrations.

Scientific and clinical studies have demonstrated that:

• Retinal converts to retinoic acid approximately 11 times faster than retinol

• Retinal offers efficacy comparable to retinoic acid but with significantly improved skin tolerance

• Retinal provides powerful anti-aging, skin-renewing, and collagen-stimulating effects with reduced irritation

For these reasons, retinal is widely recognized as one of the most advanced and effective vitamin A forms available for modern skin care formulations.

Why Choose Retinal Instead of Retinol?

Although retinol has long been used in cosmetic formulations, it presents several inherent limitations, including instability, oxidation, discoloration, and slow biological conversion.

Retinal offers distinct advantages:

• Faster efficacy – 11-fold faster conversion to retinoic acid compared with retinol

• Higher biological efficiency – closer to retinoic acid in the vitamin A metabolic pathway

• Improved skin tolerance – lower irritation potential compared with retinoic acid

• Broader functionality – supports anti-aging, acne control, skin tone improvement, and barrier repair

However, retinal itself is a chemically sensitive molecule that is prone to oxidation, light degradation, and discoloration. These challenges have historically limited its widespread use in cosmetic formulations.

NanoActive® RAL: Liposomal Retinal Technology

NanoActive® RAL overcomes the traditional limitations of retinal through an advanced liposomal nano-delivery system, enabling formulators to fully unlock the benefits of retinal in a stable, effective, and user-friendly form.

NanoActive® RAL is a lipid-encapsulated retinal, engineered using phospholipid bilayer technology that mimics the structure of biological cell membranes. This delivery system provides comprehensive protection and controlled release of retinal in the skin.

Key Features of NanoActive® RAL

• High stability – protected from oxidation, light exposure, and thermal degradation

• No discoloration – maintains formulation clarity and color stability over time

• Enhanced skin absorption – liposomal structure improves penetration and bioavailability

• Controlled release – gradual delivery minimizes irritation while maximizing efficacy

• Superior compatibility – easy to formulate into a wide range of cosmetic systems

Through nano-encapsulation, NanoActive® RAL ensures that retinal remains active, effective, and safe throughout the product’s shelf life and during skin application.

11 Times Faster Conversion to Retinoic Acid

One of the most important advantages of NanoActive® RAL is the intrinsic metabolic efficiency of retinal.

In the skin:

• Retinol → Retinal → Retinoic Acid (two-step conversion)

• Retinal → Retinoic Acid (one-step conversion)

This simplified pathway allows retinal to deliver results approximately 11 times faster than retinol, leading to quicker improvements in skin texture, tone, and visible signs of aging.

Because NanoActive® RAL enhances retinal delivery and stability, this rapid conversion can occur more efficiently and consistently within the skin.

Skin Benefits of NanoActive® RAL

NanoActive® RAL delivers a comprehensive range of clinically supported skin benefits:

Anti-Aging & Wrinkle Reduction

• Stimulates collagen and elastin synthesis

• Improves skin firmness, elasticity, and density

• Reduces the appearance of fine lines and wrinkles

Skin Renewal & Texture Improvement

• Accelerates epidermal cell turnover

• Smooths rough skin texture

• Promotes a more even and refined complexion

Brightening & Tone Correction

• Inhibits tyrosinase activity and melanin formation

• Enhances skin radiance and uniformity

• Helps fade hyperpigmentation and discoloration

Acne & Blemish Control

• Exhibits direct antibacterial activity against acne-causing bacteria

• Regulates sebum production

• Supports pore refinement and blemish recovery

Barrier Support & Repair

• Improves skin barrier integrity

• Enhances resilience against environmental stressors

• Supports long-term skin health and comfort

Superior Stability and Color Performance

Traditional retinal and retinol formulations often suffer from:

• Rapid degradation

• Yellowing or browning over time

• Loss of activity during storage

NanoActive® RAL is specifically designed to address these issues. The liposomal encapsulation effectively isolates retinal from environmental stress factors, resulting in:

• Excellent formulation stability

• Minimal color change over time

• Consistent performance throughout shelf life

This makes NanoActive® RAL ideal for premium skin care products where visual appearance, product consistency, and long-term efficacy are critical.

Easy Absorption & Skin Compatibility

The phospholipid-based nano-carriers used in NanoActive® RAL closely resemble the lipid structure of human skin. This biomimetic design allows for:

• Improved skin affinity

• Efficient penetration through the stratum corneum

• Targeted delivery to deeper skin layers

As a result, NanoActive® RAL is easily absorbed, non-greasy, and well tolerated, even in long-term use formulations.

NanoActive® RAL is suitable for a wide range of cosmetic and personal care applications, including:

• Anti-aging serums and creams

• Brightening and skin renewal products

• Acne treatment formulations

• Eye care products

• Barrier repair and post-treatment care

Its excellent compatibility allows formulators to incorporate NanoActive® RAL into emulsions, gels, lotions, and advanced delivery systems with ease.

A New Generation of Vitamin A Actives

By combining the proven biological power of retinal with state-of-the-art nano-delivery technology, NanoActive® RAL represents a new generation of vitamin A active ingredients.

It offers:

• Faster results than retinol

• Better tolerance than retinoic acid

• Greater stability than conventional retinal

• Enhanced user experience and formulation reliability

Conclusion

NanoActive® RAL (Liposomal Retinal) embodies PuriPharm Co. Ltd.’s commitment to scientific excellence, innovation, and performance. As a key product within the NanoActive® platform and a natural extension of the PuriActives® philosophy, NanoActive® RAL provides formulators and brands with a powerful, stable, and advanced vitamin A solution for next-generation skin care.

By delivering stable, non-discoloring, easily absorbed liposomal retinal with an 11-fold faster conversion to retinoic acid compared with retinol, NanoActive® RAL sets a new benchmark for efficacy, safety, and formulation sophistication in modern cosmetic science.